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Abstract 
Tuberculosis caused by Mycobacterium tuberculosis is the biggest infectious 
disease causing human death in the world. The main challenge in controlling 
tuberculosis is to quickly and accurately diagnose tuberculosis infection. 
Several kits have been produced to diagnose tuberculosis, but have 
different sensitivity and specificity. This shows that the kit is not yet ideal 
for diagnosing tuberculosis, so the search for candidates for specific 
antigens still needs to be done. One potential antigen is the Rv 1926c 
encoding MPT 63 protein. This protein is known to induce Th1 cells and 
produce IFN λ from PBMC cells of patients infected with tuberculosis. The 
purpose of this study was to clone the Rv 1926c from Mycobacterium 
tuberculosis as a tuberculosis immunodiagnostic kit. The method used is 
isolating Rv 1926c with PCR, ligation to pGEM-T vector and transformation 
to E.coli host cell JM 109. Clone characterization was carried out by PCR and 
migration analysis. The results obtained are the recombinant clones 
obtained have successfully inserted with the Rv 1926 c  
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Introduction 
Tuberculosis (TB) is the ninth leading cause of death worldwide. In 2016, there were 
an estimated 1.3 million TB deaths among HIV-negative people and an additional 374.000 
deaths among HIV-positive people. In 2016 an estimated 10.4 million people fell ill with TB: 
90% were adults, 65% were male, 10% were people living with HIV (74% in Africa) and 56% 
were in five countries: India, Indonesia, China, the Philippines and Pakistan (WHO, 2017). 
Generally most of the people in Indonesia have received the BCG vaccine when they 
were toddlers. But the effectiveness of this vaccine does not last until adulthood, so it is 
suspected that everyone can be infected by M. tuberculosis and is latent. Latent TB infection 
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has the potential to become active TB and people with active TB can be a source of new 
infections 
Latent tuberculosis infection (LTBI)  is the presence of tuberculosis in the body without 
symptoms or radiographic evidence or bacteriological examination. It is estimated that up to 
13 million people in the United States are latent TB, and 5-10% of infected people will suffer 
from TB, which is equivalent to 650,000 to 1,300,000 (CDC, 2013). 
The guidelines recommend that either Tuberculin Skin Test (TST) or Interferon gamma 
release assays (IGRA) can be use to test for latent TB in in high-income and upper middle-
income countries with estimated TB incidence less than 100 per 100 000. Consistent with 
existing WHO recommendations, the guidelines reiterated that IGRA should not replace 
tuberculin skin test in low-income and other middle-income countries (WHO, 2018). 
Tuberculin Skin Test (TST), also referred to as the Mantoux or Purified Protein 
Derivative (PPD) test, detects TB exposure through the skin. Advantages of TST are simple and 
easy to administer  and can detect TB infection. Disadvantages of TST are false negatives: the 
failure of a bump to develop can be the result of a compromised immune system, false 
positives: the bacterial particles in the BCG vaccine can stimulate the production of TB 
antibodies, causing a false positive, sensitivity varies widely across populations and is 
inconclusive for children, HIV patients with low CD4 counts (TAG, 2018).  
Some weaknesses of TST include not being able to distinguish between active and 
latent TB patients. This test will be positive in people who are BCG vaccinated and who are in 
contact with other mycobacteria (Pai et al., 2016). Therefore the specificity of PPD is 
questionable, especially in endemic areas such as Indonesia. 
Due to the limitations of the TST test, the study was directed to find the specific 
antigen to be used as an immunodiagnostic. Especially the availability of TB diagnostic 
reagents that can identify new and latent infected individuals with high risk that can develop 
into active tuberculosis. One potential antigen is the Rv1926c encoding MPT 63 protein. This 
protein is known to induce Th1 cells and produce IFN λ from PBMC cells of patients infected 
with TB.The purpose of this study was to clone the Rv 1926c from M. tuberculosis to E.coli JM 
109 as immunodiagnostic latent tuberculosis 
  
Materials and Methods 
Bacterial Strains and Plasmids 
The cloning vectors pGEM-T Easy and bacterial strain JM 109 (Promega) was used. The 
strains M. tuberculosis was obtained from clinical isolate from Indonesia. 
 
Culture Condition 
Bacterial strain JM 109 is a useful host for transformation of pGEM-T vector. Bacterial 
were incubate with stirring over night in Luria- Bertani medium in the presence of ampicillin 
(1μg/ml) at 37°C. The clinical isolate of M. tuberculosis is cultured in the Lowenstein-Jensen  
medium. 
 
Chromosome DNA extraction 
M.tuberculosis chromosome DNA extracted using Qiagen DNeasy kit. DNA extraction 
were measured using a spectrophotometer at absorbance of 260 nm. 
 
Amplification  
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Amplification of Rv 1926c was carried out by PCR using a specific primer. The primer 
sequence used in this study according (5) as follow Forward: 5'-
CAGCAGGATCCCGCCTATCCCATCACCGGA-3' and Reverse : 5’-
GCCCAAGCTTCGGCTCCCAAATCAGCAG-3' .The PCR conditions for amplification were pre 
denaturation 940C 10 minutes,  denaturation 940C 1 minute, annealing 560C 1 minute and 
elongation 720C 1 minute in 30 cycles. 
 
 
Creation of Plasmid of the Recombinant Rv 1926c in E. coli JM 109 
Fragment of the Rv 1926c were obtained by PCR using two primers pair and DNA of 
the M. tuberculosis Indonesian strain as a template. The pGEM-T vector and PCR product were 
cut with BamHI and HindIII, mixed, and treated with T4 DNA ligase. The resulting recombinant 
plasmid pGEM-T-Rv1926 was transformed in E. coli JM 109. 
 
Transformation 
Isolation of DNA and transformation of the E. coli JM 109 cells were performed as 
described in the guidebook [6], with the following modifications. Transformed cells were 
spread on the appropriate indicator plates containing ampicillin. Colonies were scored for 
phenotype on Luria Bertani agar plates after 24 hours at 37°C. 
 
Results and Discussion  
PCR Product and Purification 
The results of PCR amplification of Rv 1926 observed by electrophoresis agarosa. A 
band was revealed which corresponded to the gene with the apparent of  412 bp. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.  PCR product of Rv 1926c, (K-) Negative control , (1,2) Rv 1926c , (K+) Positive 
control , (M 100) Marker 100 bp 
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Ligation and transformation of the Rv 1926c to the pGEM-T vector 
The results of the transformation in Figure 1 showed that there were colonies and 
white colonies in petridish containing LB medium, X-gal, IPTG and ampicillin. White colonies 
indicate that the insertion DNA has been successfully inserted into the vector, while the blue 
colony means that the insertion DNA has not been successfully transferred to the vector. 
White E. coli colonies (transformant cells) showed Rv 1926c coding DNA successfully ligated 
in the MCS (multi cloning site) area found in the lacZ pGEM-T gene. The insertion of this DNA 
fragment will inhibit the lacZ gene to encode the subunit of β-galactosidase, so that the 
enzyme cannot degrade the available galactose substrate. The bacterial colonies are blue, 
meaning they do not have insertion DNA fragments so they can degrade the available 
galactose substrate (Medical Biochemistry, 2017). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Recombinant clone pGEM-T-Rv 1926c 
 
Characterization of Recombinant Plasmid of pGEM-T-Rv 1926c  
Isolation of plasmid were performed according to the procedure instructions (BioRad). 
Characterization was done by PCR analysis and migration analysis. Migration analysis was 
done by comparing pGEM-T (3000 bp) and pGEM-T-Rv 1926c (3412 bp). A band shows 
difference length while pGEM-T-Rv1926c had slower migration than pGEM-T (Figure 3).  
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Figure 3. Migration analysis: (1) pGEM-T: 3000 bp (2) pGEM-T-Rv1926: 3412bp 
 
This suggests that the plasmid without insert DNA (pGEM-T) will move faster than the 
recombinant plasmid (pGEM-T-Rv 1926c). This means that the DNA inserts Rv 1926c has been 
successfully ligation into the vector pGEM-T. PCR analysis was done by using exactly the same 
cycle as it mentioned before for amplified the Rv 1926c gene. Electrophoresis showed that 
plasmid recombinant contain the Rv 1926c gene as DNA insert was 412 bp (Figure 4) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                       
 
Figure 4. PCR analysis: (A,B,C,D) Rv 1926c : 412bp. (M) Marker 100 bp 
 
Conclusions 
Gene of  Rv 1926c  M. tuberculosis Indonesian isolates have been successfully ligated 
to pGEM-T vectors and transformed into E. coli JM 109 
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